Guangxi LiuYao Group Co., Ltd

603368

CNE100001VR3

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-06-05 pm EDT			5-day change	1st Jan Change
21.07 ^CNY	-0.66%		-4.14%	+11.36%

May. 31	Guangxi Xianzhu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 50 million in funding from Guangxi LiuYao Group Co., Ltd	CI
Apr. 25	Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Guangxi Liuzhou Pharmaceutical Co Ltd Appoints Su Chunyan as Chief Financial Officer

March 27, 2017 at 06:30 am EDT

Guangxi Liuzhou Pharmaceutical Co Ltd. has appointed Su Chunyan as chief financial officer of the company. Currently, Chunyan serves at Guangxi Liuzhou Pharmaceutical Co Ltd. as its controller.

Latest news about Guangxi LiuYao Group Co., Ltd

Guangxi Xianzhu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 50 million in funding from Guangxi LiuYao Group Co., Ltd	May. 30	CI
Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Guangxi Liuyao Gets Shanghai Bourse's Nod to Issue Shares	Apr. 22	MT
Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Guangxi LiuYao Group Co., Ltd(XSSC:603368) added to S&P Global BMI Index	23-09-18	CI
Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Tranche Update on Guangxi LiuYao Group Co., Ltd's Equity Buyback Plan announced on November 15, 2022.	23-05-12	CI
Guangxi LiuYao Group Co., Ltd's Equity Buyback announced on November 15, 2022 has closed with 2,416,200 shares, representing 0.67% for CNY 51 million.	23-05-11	CI
Guangxi LiuYao Group Co., Ltd announced that it expects to receive CNY 1 billion in funding	23-04-19	CI
Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-18	CI
Tranche Update on Guangxi LiuYao Group Co., Ltd's Equity Buyback Plan announced on November 15, 2022.	23-04-03	CI
Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Guangxi LiuYao Sees 22.8% Jump in 2022 Profit	23-02-09	MT
Tranche Update on Guangxi LiuYao Group Co., Ltd's Equity Buyback Plan announced on November 15, 2022.	23-01-03	CI
Guangxi LiuYao to Repurchase Up to $14 Million Shares	22-11-15	MT
Guangxi LiuYao Group Co., Ltd announces an Equity Buyback for CNY 100 million worth of its shares.	22-11-15	CI
Guangxi LiuYao Group Co., Ltd authorizes a Buyback Plan.	22-11-13	CI
Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Guangxi LiuYao Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-10	CI
Guangxi Liuzhou Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-27	CI
Guangxi Liuzhou Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Guangxi Liuzhou Pharmaceutical Co., Ltd.(XSSC:603368) dropped from S&P Global BMI Index	21-12-20	CI
Guangxi Liuzhou Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Guangxi Liuzhou Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-18	CI

Chart Guangxi LiuYao Group Co., Ltd

Duration

Period

More charts

Guangxi LiuYao Group Co Ltd, formerly Guangxi Liuzhou Pharmaceutical Co Ltd, is a China-based company mainly engaged in the sales of pharmaceuticals. The Company is mainly engaged in three businesses. The pharmaceutical wholesale business mainly distributes pharmaceutical products to medical and health institutions at all levels, pharmaceutical distribution enterprises and chain pharmacies. The pharmaceutical retail business provides sales and health services of various pharmaceutical products, medical devices and other pharmaceutical products to individual consumers through terminal pharmacies. The pharmaceutical industry business is mainly engaged in the production and processing of traditional Chinese medicine pieces and traditional Chinese medicine formula granules. The Company is also engaged in supply chain value-added services, pharmaceutical Internet services, terminal health services and others.

Sector

Pharmaceuticals

Calendar

2024-06-17 - Extraordinary Shareholders Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Guangxi LiuYao Group Co., Ltd

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

21.07 CNY

Average target price

31.29 CNY

Spread / Average Target

+48.50%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
GUANGXI LIUYAO GROUP CO., LTD	+11.36%	1.16B
MCKESSON CORPORATION	+26.94%	76.19B
CARDINAL HEALTH, INC.	-2.01%	24.06B
SINOPHARM GROUP CO. LTD.	+10.27%	8.83B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+10.22%	8.51B
HUADONG MEDICINE CO., LTD	-22.96%	7.72B
H. LUNDBECK A/S	+12.27%	5.2B
GALENICA AG	+3.02%	4.18B
EBOS GROUP LIMITED	-5.61%	4.01B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+4.85%	3.86B

Pharmaceuticals Wholesale

Guangxi LiuYao Group Co., Ltd

Equities

603368

CNE100001VR3

Pharmaceuticals

Guangxi Liuzhou Pharmaceutical Co Ltd Appoints Su Chunyan as Chief Financial Officer

Latest news about Guangxi LiuYao Group Co., Ltd

Chart Guangxi LiuYao Group Co., Ltd

Company Profile

Income Statement Evolution

Ratings for Guangxi LiuYao Group Co., Ltd

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Pharmaceuticals Wholesale